Mortality and the risk of malignancy in autoimmune liver diseases: A population‐based study in Canterbury, New Zealand

@article{Ngu2012MortalityAT,
  title={Mortality and the risk of malignancy in autoimmune liver diseases: A population‐based study in Canterbury, New Zealand},
  author={Jing Hieng Ngu and Richard Blair Gearry and Chris Miles Frampton and Catherine Ann Malcolm Stedman},
  journal={Hepatology},
  year={2012},
  volume={55}
}
  • Jing Hieng Ngu, Richard Blair Gearry, +1 author Catherine Ann Malcolm Stedman
  • Published 2012
  • Medicine
  • Hepatology
  • Population‐based quantitative data on the mortality and cancer incidence of autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC) are scarce. Our aim was to systematically investigate the survival and risk of malignancy on population‐based cohorts of AIH, PBC, and PSC in Canterbury, New Zealand. Multiple case‐finding methods were employed, including searches of all public and private, adult and pediatric outpatient clinics, hospital notes… CONTINUE READING
    45 Citations
    Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis
    • 17
    Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis – a long-term follow-up study in 634 Swedish patients
    • 22
    Mortality on the UNOS Waitlist for Patients with Autoimmune Liver Disease
    • PDF
    Extrahepatic Malignancies in Primary Biliary Cirrhosis: A Comparative Study at Two European Centers
    • 22
    Risk factors for hepatic decompensation in patients with primary biliary cirrhosis.
    • 17
    Autoimmune hepatitis: the role of environmental risk factors: a population-based study
    • 18
    Hepatocellular Carcinoma and Other Malignancies in Autoimmune Hepatitis
    • A. Czaja
    • Medicine
    • Digestive Diseases and Sciences
    • 2012
    • 32
    • Highly Influenced

    References

    SHOWING 1-10 OF 45 REFERENCES
    Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis.
    • 78
    Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.
    • 563
    Cancer risk in primary biliary cirrhosis: A population‐based study from Sweden
    • 85